arrow_back Back to App

Combating Illicit Xylazine: New Rules for Veterinary Drug

This act aims to curb the illicit use of xylazine, a veterinary substance, by adding it to the list of controlled substances. Citizens who own animals or work with them will still be able to legally use xylazine under new guidelines, but its illegal possession and distribution will face stricter penalties. The changes are intended to enhance public safety and combat the misuse of this substance.
Key points
Xylazine, a veterinary drug, will be added to the list of controlled substances, leading to stricter penalties for its illicit use.
Individuals owning animals or involved in animal control programs can still legally possess xylazine if obtained from a veterinarian or pharmacy with a prescription.
Transition periods are provided for manufacturers and practitioners to comply with new labeling, storage, and record-keeping requirements.
Authorities will monitor the prevalence of illicit xylazine use and report findings to Congress.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_1266
Sponsor: Rep. Panetta, Jimmy [D-CA-19]
Process start date: 2025-02-12
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Combating Illicit Xylazine Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_1266.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-02-12.

What are the main provisions?

Key points include:

  • Xylazine, a veterinary drug, will be added to the list of controlled substances, leading to stricter penalties for its illicit use.
  • Individuals owning animals or involved in animal control programs can still legally possess xylazine if obtained from a veterinarian or pharmacy with a prescription.
  • Transition periods are provided for manufacturers and practitioners to comply with new labeling, storage, and record-keeping requirements.
  • Authorities will monitor the prevalence of illicit xylazine use and report findings to Congress.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Panetta, Jimmy [D-CA-19].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health Courts and Law